Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. C. Cofta, E. W. Wysocka, J. G. Gozdzik, L. T. Torlinski, H. B. G. Batura-Gabryel (Poznan, Poland). LATE-BREAKING ABSTRACT: The impact of glucose tolerance on superoxide dismutase-1 activity in erythrocyte of obstructive sleep apnea males. Eur Respir J 2009; 34: Suppl. 53, 3024

Member's Comments

No comment yet.

Related content which might interest you: Superoxide dysmutase activity and its provided factors in persons with different stages of obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006 Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005 LATE-BREAKING ABSTRACT: Effects of APOE genotype and hypoxia on plasma lipids in obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 The impact of obstructive sleep apnea syndrome on superoxide dysmutase-1 activity in erythrocytes of high risk for type 2 diabetes (pre-diabetic) males Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011 The influence of glucose tolerance on plasma oxidative stress markers in obstructive sleep apnea males Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome Source: Eur Respir J 2008; 31: 1046-1053 Year: 2008 Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA Source: Eur Respir J 2016; 47: 1012-1014 Year: 2016 Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA Source: Eur Respir J 2016; 47: 1014-1015 Year: 2016 Lipid peroxidation and antioxidant status in the pathogenesis of obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Erythrocyte production in obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004 Plasma total antioxidant status in obstructive sleep apnea men Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005 Evaluation of 8-isoprostane as a biomarker of oxidative stress in children with obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012 Erythrocyte glycolysis in severe obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Neutrophil ROS production in obese and non-obese men with different severity of obstructive sleep apnoea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS) Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004 Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 573s Year: 2006 Effect of N-acetylcysteine on polysomnography parameters in patients of obstructive sleep apnea with metabolic syndrome Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007